SAN DIEGO, Feb. 2, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is recognizing its first-ever pair of Brand Ambassadors to reach the company’s Crown Ambassador Elite rank.
Randy and Samantha Schroeder have achieved the rank of Crown Ambassador Elite, which requires achieving a minimum of $1 million in monthly business volume. They have been recognized numerous times for their dedication to educate others about Kannaway’s® cannabidiol (CBD) hemp oil products. Now, Randy and Samantha are one more step closer to Kannaway®’s top rank – Double Crown Ambassador.
“In Kannaway, there is no solitary success. In reaching upper ranks, widespread successes of organization members are a prerequisite to personal advancement,” said Kannaway® Brand Ambassador Randy Schroeder. “Samantha and I are very grateful to many Brand Ambassadors who have made our latest advancement possible.”
“We are very proud of Randy and Samantha’s achievement,” said Kannaway® CEO Blake Schroeder. “Their commitment and drive sets an example we all can learn from, and they are leading our company to unprecedented levels, something we are proud of.”
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who wish to become successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media